Clinical Information and PET Results for 37 NPC Patients with Questionable MRI Findings for Residual or Recurrent Disease
| Patient no. | Age (y) | Sex | Initial stage | Treatment mode | Interval* (m) | PET result | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Node | Distance | Overall | |||||||||
| 1 | 40 | M | T4 N2 M0 | IMRT + CC | 6.8 | FP | TN | TN | FP | |||
| 2 | 49 | M | T4 N0 M0 | IMRT + CC | 4.2 | TN | TN | TN | TN | |||
| 3 | 38 | F | T2 N2 M0 | IMRT + CC | 3.9 | FP | TN | TN | FP | |||
| 4 | 49 | M | T3 N0 M0 | IMRT + CC | 12.7 | TP | TN | TN | TP | |||
| 5 | 53 | M | T1 N2 M0 | IMRT + BB | 14.3 | FP | TN | TN | FP | |||
| 6 | 60 | M | T1 N0 M0 | IMRT + BB | 24.2 | FP | TN | TN | FP | |||
| 7 | 44 | F | T2 N1 M0 | IMRT | 12.5 | FN | TN | TN | FN | |||
| 8 | 42 | M | T3 N1 M0 | IMRT + CC | 23.5 | TP | TN | TP | TP | |||
| 9 | 44 | M | T3 N2 M0 | IMRT + CC | 3.8 | TN | FN | TN | FN | |||
| 10 | 59 | F | T2a N1 M0 | IMRT | 4.9 | TN | TP | TN | TP | |||
| 11 | 47 | M | T1 N2 M0 | IMRT + BB | 4.3 | TN | FP | TN | FP | |||
| 12 | 64 | F | T2 N1 M0 | IMRT | 6.8 | TN | TP | TN | TP | |||
| 13 | 70 | M | T2 N1 M0 | IMRT | 112.6 | TN | TN | TN | TN | |||
| 14 | 34 | M | T4 N2 M0 | IMRT + CC | 3.7 | TP | TP | TN | TP | |||
| 15 | 41 | M | T3 N2 M0 | IMRT + CC | 3.9 | FP | TN | TP | TP | |||
| 16 | 49 | M | T3 N0 M0 | IMRT + CC | 3.7 | FP | TN | TN | FP | |||
| 17 | 43 | F | T1 N2 M0 | IMRT + BB | 3.8 | TN | TP | TP | TP | |||
| 18 | 44 | F | T2b N2 M0 | IMRT + CC | 15.9 | TP | TP | TN | TP | |||
| 19 | 59 | M | T4 N0 M0 | IMRT + CC | 3.7 | TN | TN | TN | TN | |||
| 20 | 50 | M | T3 N0 M0 | IMRT + CC | 12.2 | TP | TN | TP | TP | |||
| 21 | 29 | M | T3 N1 M0 | IMRT + CC | 3.9 | TN | TN | FP | FP | |||
| 22 | 35 | M | T4 N2 M0 | IMRT + CC | 13.1 | TP | TN | TN | TP | |||
| 23 | 16 | F | T4 N2 M0 | IMRT + CC | 4.2 | TN | TN | TN | TN | |||
| 24 | 76 | M | T4 N0 M0 | IMRT + CC | 3.9 | TN | TN | TN | TN | |||
| 25 | 45 | F | T4 N3 M0 | IMRT + CC | 10.5 | TP | TP | FP | TP | |||
| 26 | 51 | F | T1 N0 M0 | IMRT + BB | 90.2 | TP | FP | FP | TP | |||
| 27 | 40 | M | T3 N1 M0 | IMRT + CC | 3.7 | TN | FP | TN | FP | |||
| 28 | 45 | F | T2b N2 M0 | IMRT + CC | 13.9 | TN | TN | TN | TN | |||
| 29 | 45 | F | T2b N0 M0 | IMRT | 3.9 | TP | TP | TN | TP | |||
| 30 | 43 | M | T1 N0 M0 | IMRT + BB | 39.6 | TN | TP | TN | TP | |||
| 31 | 38 | M | T1 N1 M0 | IMRT + BB | 3.8 | TN | TN | TN | TN | |||
| 32 | 40 | M | T4 N0 M0 | IMRT + CC | 31.2 | TP | TN | TN | TP | |||
| 33 | 47 | F | T2b N2 M0 | IMRT + CC | 3.8 | TN | TN | TN | TN | |||
| 34 | 42 | F | T4 N1 M0 | IMRT + CC | 3.9 | TN | TN | TN | TN | |||
| 35 | 66 | M | T4 N1 M0 | IMRT + CC | 4.3 | TN | TN | TN | TN | |||
| 36 | 63 | M | T3 N3 M0 | IMRT + CC | 3.8 | TP | TP | TN | TP | |||
| 37 | 48 | M | T4 N2 M0 | IMRT + CC | 3.7 | TN | TN | TP | TP | |||
IMRT = intensity-modulated radiation therapy; IMRT + CC = IMRT with concurrent chemotherapy; IMRT + BB = IMRT with brachytherapy boost; TP = true positive; FP = false positive; TN = true negative; FN = false negative.
↵* Between the complement of therapy and 18F-FDG PET.